November 5, 2013

Drug Company To Pay $2 billion Fine for Unapproved Use of Drugs


[from article]
In criminal filings Monday, the Justice Department said Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, marketed Risperdal for unapproved uses. The drug, approved to treat only schizophrenia, was marketed to also treat anxiety, agitation, depression and other symptoms, the Justice Department said.

http://www.latimes.com/business/money/la-fi-mo-johnson-johnson-settlement-20131104,0,2453644.story#axzz2ji3Bk2NT

Johnson & Johnson to pay $2.2 billion for illegal drug marketing
By Ricardo Lopez
November 4, 2013, 11:56 a.m.
Los Angeles Times

No comments: